Omeros Net Long-Term Debt 2010-2025 | OMER
Omeros Annual Net Long-Term Debt (Millions of US $) |
|
---|---|
2024 | $-41 |
2023 | $-101 |
2022 | $0 |
2021 | $N/A |
2020 | $76 |
2019 | $N/A |
2018 | $77 |
2017 | $N/A |
2016 | $24 |
2015 | $15 |
2014 | $11 |
2013 | $N/A |
2012 | $0 |
2011 | $9 |
2010 | $-3 |
2009 | $-4 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.221B | $0.000B |
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $232.094B | 27.91 |
Boston Scientific (BSX) | United States | $148.004B | 37.05 |
Stryker (SYK) | United States | $145.912B | 30.51 |
EssilorLuxottica (ESLOY) | France | $130.051B | 0.00 |
Medtronic (MDT) | Ireland | $112.158B | 15.90 |
Lonza Group Ag (LZAGY) | Switzerland | $50.407B | 0.00 |
Haleon (HLN) | United Kingdom | $48.971B | 27.90 |
ResMed (RMD) | United States | $36.801B | 27.64 |
Agilent Technologies (A) | United States | $33.162B | 21.62 |
GE HealthCare Technologies (GEHC) | United States | $32.817B | 15.58 |
Terumo (TRUMY) | Japan | $26.665B | 34.63 |
Koninklijke Philips (PHG) | Netherlands | $22.070B | 15.86 |
Insulet (PODD) | United States | $21.511B | 84.44 |
Zimmer Biomet Holdings (ZBH) | United States | $18.366B | 11.80 |
Baxter (BAX) | United States | $15.831B | 11.82 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.086B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
Demant (WILYY) | Denmark | $8.854B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.138B | 21.36 |
Lantheus Holdings (LNTH) | United States | $5.758B | 14.52 |
Prestige Consumer Healthcare (PBH) | United States | $4.234B | 18.91 |
Perrigo (PRGO) | Ireland | $3.598B | 9.12 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Haemonetics (HAE) | United States | $3.442B | 15.68 |
ICU Medical (ICUI) | United States | $3.353B | 24.73 |
Envista Holdings (NVST) | United States | $3.224B | 26.79 |
GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
QuidelOrtho (QDEL) | United States | $2.043B | 14.05 |
LeMaitre Vascular (LMAT) | United States | $1.883B | 42.08 |
AtriCure (ATRC) | United States | $1.692B | 0.00 |
Acuren (TIC) | United States | $1.348B | 0.00 |
Neogen (NEOG) | United States | $1.198B | 15.33 |
AdaptHealth (AHCO) | United States | $1.190B | 12.08 |
BioLife Solutions (BLFS) | United States | $1.132B | 0.00 |
Kestra Medical Technologies (KMTS) | United States | $1.087B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.082B | 24.33 |
Phibro Animal Health (PAHC) | United States | $0.982B | 12.55 |
InMode (INMD) | Israel | $0.920B | 9.27 |
CeriBell (CBLL) | United States | $0.644B | 0.00 |
Evolus (EOLS) | United States | $0.622B | 0.00 |
Owens & Minor (OMI) | United States | $0.613B | 5.08 |
Capricor Therapeutics (CAPR) | United States | $0.611B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.581B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.581B | 0.00 |
Valneva SE (VALN) | France | $0.517B | 0.00 |
Surmodics (SRDX) | United States | $0.417B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.413B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.351B | 12.91 |
SNDL (SNDL) | Canada | $0.349B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.327B | 58.20 |
Canopy Growth (CGC) | Canada | $0.298B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
Cerus (CERS) | United States | $0.281B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
Cresco Labs (CRLBF) | United States | $0.263B | 0.00 |
ZimVie (ZIMV) | United States | $0.261B | 11.89 |
Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.258B | 0.00 |
Biote (BTMD) | United States | $0.215B | 6.05 |
OraSure Technologies (OSUR) | United States | $0.214B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
Brainsway (BWAY) | Israel | $0.208B | 55.05 |
Quanterix (QTRX) | United States | $0.196B | 0.00 |
High Tide (HITI) | Canada | $0.191B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.185B | 15.08 |
Organigram Global (OGI) | Canada | $0.185B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.184B | 0.00 |
Exagen (XGN) | United States | $0.153B | 0.00 |
FitLife Brands (FTLF) | United States | $0.133B | 16.40 |
Vireo Growth (VREOF) | United States | $0.129B | 0.00 |
Jin Medical (ZJYL) | China | $0.107B | 0.00 |
MacroGenics (MGNX) | United States | $0.103B | 0.00 |
Veru (VERU) | United States | $0.095B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
Fonar (FONR) | United States | $0.089B | 11.50 |
TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
Agape ATP (ATPC) | $0.075B | 0.00 | |
InterCure (INCR) | Israel | $0.069B | 0.00 |
Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
Zynex (ZYXI) | United States | $0.066B | 0.00 |
Apyx Medical (APYX) | United States | $0.065B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
ImmuCell (ICCC) | United States | $0.058B | 0.00 |
Modular Medical (MODD) | United States | $0.044B | 0.00 |
Nephros (NEPH) | United States | $0.040B | 54.43 |
United-Guardian (UG) | United States | $0.038B | 13.25 |
Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
Safety Shot (SHOT) | United States | $0.020B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
INLIF (INLF) | $0.016B | 0.00 | |
Flora Growth (FLGC) | United States | $0.014B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Senestech (SNES) | United States | $0.005B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |